NCT06081296 is a NA clinical trial of Control group in Alveolar Bone Loss, sponsored by Renato Casarin.

Who is sponsoring NCT06081296?

NCT06081296 is sponsored by Renato Casarin.

What drugs are being tested in NCT06081296?

Interventions in NCT06081296: Control group, Mixed free gingival graft group, Bone+ mixed free gingival graft group, Bone + Titanium Seal group.

What condition does NCT06081296 study?

NCT06081296 studies Alveolar Bone Loss.

Is NCT06081296 still recruiting?

NCT06081296 is currently status unknown. Last updated 13 October 2023.

Last reviewed 2023-10-13 · How we verify

NCT06081296

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dimensional Changes in Alveolar Ridge Preservation

Status unknown NA Last updated 13 October 2023

What this trial tests

NA trial testing Control group in Alveolar Bone Loss in 80 participants. Status unknown.

Timeline

1 September 2022

Primary endpoint
15 October 2023

1 September 2024

Quick facts

Lead sponsor	Renato Casarin
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	triple
Primary purpose	treatment
Enrollment	80
Start date	1 September 2022
Primary completion	15 October 2023
Estimated completion	1 September 2024
Sites	1 location across Brazil

Drugs / interventions tested

Control group — full drug profile →
Mixed free gingival graft group
Bone+ mixed free gingival graft group
Bone + Titanium Seal group

Conditions studied

Alveolar Bone Loss — all drugs for Alveolar Bone Loss →

Sponsor

Renato Casarin

Who can join

18 and older, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: The objective is to evaluate the dimensional changes of soft tissue and alveolar ridge after extraction of posterior elements with different clinical protocols of alveolar preservation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Dimensional Changes After Different Alveolar Ridge Preservation Techniques for Posterior Region: A Randomised Controlled Clinical Trial.
Sandoli Arroteia L, Lopes MP, Réa MT, Vieira E Oliveira TR, et al · · 2025 · cited 5× · PMID 40762250 · DOI 10.1111/jcpe.70004

Verify or expand the search:

Other trials of Control group

Trials testing the same drug.

NCT07510555 — The Effect of a Mindfulness-Based Stress Reduction Program Applied to Nulliparous Pregnant Women · NA · not yet recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07494292 — Personalised Active Self-management of Sleep Apnea Program · NA · not yet recruiting
NCT07483775 — Feasibility and Health-economic Evaluation of Remote Clinical Monitoring Enabling Same-day Discharge After Bariatric Sur · NA · not yet recruiting
NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

NCT07508033 — Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing · Phase 1, PHASE2 · recruiting
NCT07375004 — Injectable PRF in Non-Surgical Periodontal Treatment · NA · active not recruiting
NCT07449806 — Assessment of Labial Plate Thickness After Immediate Implant Placement Using Two Different Xenografts in the Esthetic Zo · NA · recruiting
NCT07419269 — Comparison of Customized Allogenic Versus Autogenous Bone Block Graft for Alveolar Ridge Augmentation · NA · recruiting
NCT06887582 — Crestal Sinus Lifting in Periodontally-Compromised Patients Utilizing Autologous Dentin Graft · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06081296 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Renato Casarin
Last refreshed: 13 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06081296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing